Literature DB >> 2464640

Characteristics of B cell proliferation and activation in murine AIDS.

D M Klinman1, H C Morse.   

Abstract

A syndrome characterized by lymphadenopathy, hypergammaglobulinemia, and immunodeficiency develops in C57BL/6 mice inoculated with LP-BM5 murine leukemia viruses. By studying the number and antigenic specificity of B cells activated in the course of this disease, we found that a series of reproducible changes in the humoral immune system were induced by retroviral infection. The rate of B cell proliferation and the proportion of B cells activated to secrete Ig increased by nearly 10-fold at 4 wk post inoculation. B cells producing antibodies reactive with a panel of three conventional Ag and five autoantigens were stimulated simultaneously and proportionally to secrete, demonstrating that such activation was polyclonal in nature. At 12 wk post infection, the number of Ig-secreting B cells continued to rise and significant hypergammaglobulinemia developed. At 16 wk post infection, immunostimulation gave way to immunosuppression, as evidenced by a slight decline in the number of Ig-secreting lymphocytes and a sharp reduction in the concentration of serum antibody. At this time, the B cell repertoires of infected mice diverged markedly from those of uninfected animals. These changes are comparable to those found in some patients infected with HIV, and provide a useful model to study the association between retroviral infection and regulatory abnormalities of the humoral immune system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2464640

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Murine AIDS requires CD154/CD40L expression by the CD4 T cells that mediate retrovirus-induced disease: Is CD4 T cell receptor ligation needed?

Authors:  Wen Li; William R Green
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

2.  Effects of non-MHC loci on resistance to retrovirus-induced immunodeficiency in mice.

Authors:  M Makino; W F Davidson; T N Fredrickson; J W Hartley; H C Morse
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8+ T cells or perforin.

Authors:  Y Tang; A W Hügin; N A Giese; L Gabriele; S K Chattopadhyay; T N Fredrickson; D Kägi; J W Hartley; H C Morse
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 4.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

5.  Th0-like CD4+ T cells protect mice with murine retrovirus-induced immunodeficiency syndrome (MAIDS) against co-infection with Listeria monocytogenes.

Authors:  K Hiromatsu; H Nishimura; K Kimura; Y Aoki; J Usami; N Kobayashi; M Makino; Y Yoshikai
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

6.  The role of CD4 T cells in the pathogenesis of murine AIDS.

Authors:  Wen Li; William R Green
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency.

Authors:  Kathy A Green; W James Cook; William R Green
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

8.  Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs.

Authors:  C Simard; M Huang; P Jolicoeur
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.

Authors:  K A Green; K M Crassi; J D Laman; A Schoneveld; R R Strawbridge; T M Foy; R J Noelle; W R Green
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency.

Authors:  W R Green; K A Green; K M Crassi
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.